# Mangoceuticals, Inc.: Form 8-K, filed Jun 5, 2024

- Company: [Mangoceuticals, Inc.](/companies/mgrx.md) (CIK 1938046)
- Form: 8-K
- Filed: 2024-06-05
- Accepted by EDGAR: Jun 5, 2024, 17:15 ET
- Period: 2024-06-03
- Accession: 0001493152-24-022808
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1938046/000149315224022808/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1938046/000149315224022808/

## Items reported

- Item 3.02: Unregistered sale of equity
- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1938046/000149315224022808/form8-k.htm

Filed Jun 5, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-022808. Last ingested by Listed: Nov 15, 2026, 00:08 ET. No prices; not investment advice.
